Xipamide

Xipamide (CAS No.: 14293-44-8) is a synthetic small molecule in the sulfonamide class and is broadly categorized as a diuretic pharmacology tool compound for renal and cardiovascular biology research, with primary utility in studies of epithelial ion transport and blood pressure regulatory mechanisms under experimental conditions. Available evidence indicates that its principal mechanistic profile involves inhibition of carbonic anhydrase associated processes, suppression of sodium and chloride cotransport related salt reabsorption, and inhibition of anion exchange activity, including effects consistent with reduced renal sodium chloride reclamation and altered downstream handling of potassium, magnesium, and calcium in nephron relevant systems, while reports also note minimal interference with endothelin 1 evoked calcium signaling and limited impact on selected erythrocyte ion cotransport and pump functions. In biomedical research workflows, Xipamide is therefore commonly positioned as a pathway modulator for interrogating renal electrolyte homeostasis, fluid balance physiology, and cardio renal functional coupling in cell based assays and animal models, including disease relevant experimental contexts such as hypertension associated remodeling, impaired renal function states, and edema related pathophysiology, with concentrations in vitro generally described in the micromolar domain and sometimes extending from high nanomolar to low micromolar ranges depending on assay design, readout sensitivity, and target system. As with many legacy ion transport modulators, detailed potency constants can vary across platforms and may be incompletely standardized in public sources, so study specific optimization is typically required, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.